MedPath

海南林恒制药股份有限公司

Ownership
-
Established
1994-05-04
Employees
-
Market Cap
-
Website
https://www.linheng.com.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

18

NMPA:18

Drug Approvals

Memantine Hydrochloride Tablets

Product Name
盐酸美金刚片
Approval Number
国药准字H20244956
Approval Date
Sep 19, 2024
NMPA

Glucosamine Sulfate Capsules

Product Name
硫酸氨基葡萄糖胶囊
Approval Number
国药准字H20244884
Approval Date
Sep 10, 2024
NMPA

治带片

Approval Number
国药准字Z20053236
Approval Date
Jul 19, 2024
NMPA

Alprazolam Tablets

Product Name
阿普唑仑片
Approval Number
国药准字H46020641
Approval Date
Jul 18, 2024
NMPA

复方丹参片

Approval Number
国药准字Z46020091
Approval Date
Jul 18, 2024
NMPA

Febuxostat Tablets

Product Name
非布司他片
Approval Number
国药准字H20243520
Approval Date
Apr 17, 2024
NMPA

Calcium Dobesilate Dispersible Tablets

Product Name
羟苯磺酸钙分散片
Approval Number
国药准字H20080644
Approval Date
Nov 25, 2022
NMPA

Metronidazole,Clotrimazole and Chlorhexidine Acetate Vaginal Effervescent Tablets

Product Name
双唑泰阴道泡腾片
Approval Number
国药准字H20063174
Approval Date
Oct 20, 2020
NMPA

Fluconazole Capsules

Product Name
氟康唑胶囊
Approval Number
国药准字H20033091
Approval Date
Jun 17, 2020
NMPA

螺旋藻胶囊

Approval Number
国药准字Z46020076
Approval Date
Jun 10, 2020
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.